Frankfurt parade sees innovative German medtechs eyeing strong Aufschwung in 2008
This article was originally published in Clinica
Low - or no - growth is firmly in the rear-view mirror for Germany's medtech manufacturers, if the apparent mood at last week's MedTechDay 2008, in Frankfurt, was anything to go by. While recent years have seen companies in the world's third-largest medtech market bemoaning poor domestic sales - while overseas business has undergone a mini-boom - 2008 (like 2007) will be a different story: a strong "Aufschwung".
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.